Published in Blood Weekly, July 24th, 1995
The option includes exclusive rights to an issued U.S. patent covering clotrimazole for this use, as well as rights to data from preclinical and pilot clinical studies conducted to date.
Clotrimazole has a long history of use in humans as an antifungal agent. The rationale for using clotrimazole to treat sickle cell anemia is based on its ability to prevent the dehydration of red blood...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.